BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/22/2025 9:36:44 AM | Browse: 15 | Download: 33
 |
Received |
|
2025-03-13 08:57 |
 |
Peer-Review Started |
|
2025-03-13 08:57 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-04-09 12:43 |
 |
Revised |
|
2025-04-22 13:46 |
 |
Second Decision |
|
2025-06-03 02:53 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-06-03 10:25 |
 |
Articles in Press |
|
2025-06-03 10:25 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-07-09 09:07 |
 |
Publish the Manuscript Online |
|
2025-07-22 09:23 |
ISSN |
2218-4333 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Minireviews |
Article Title |
Revolutionizing cancer care: Bioprinting prostate cancer stem cells for targeted treatments
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jaimina Gharia, Shriya Pimplaskar and Akhilesh Prajapati |
Funding Agency and Grant Number |
|
Corresponding Author |
Akhilesh Prajapati, Assistant Professor, PhD, Department of LifeSciences Biotechnology division, School of Science, GSFC University, Vadodara 391750, Gujarat, India. akhileshbiotech06@gmail.com |
Key Words |
3D bioprinting; Prostate cancer stem cells; Cancer therapy; Precision medicine; Tumor microenvironment; Drug screening |
Core Tip |
Three-dimensional (3D) bioprinting is revolutionizing prostate cancer (PCa) research by replicating tumor microenvironments, enabling drug screening, and advancing personalized medicine. By mimicking the extracellular matrix and incorporating stromal and immune components, bioprinted models enhance physiological relevance. This technology facilitates targeted therapies by screening novel drugs tailored to individual patient profiles. However, challenges such as scalability, bioink optimization, and regulatory frameworks remain. Advances in microfluidic-assisted printing and artificial intelligence driven optimization can improve reproducibility. Integrating bioprinted models with organ-on-a-chip systems further enhances translational research. Collaborative efforts will accelerate clinical applications, positioning 3D bioprinting as a game-changer in personalized PCa treatment. |
Publish Date |
2025-07-22 09:23 |
Citation |
<p>Gharia J, Pimplaskar S, Prajapati A. Revolutionizing cancer care: Bioprinting prostate cancer stem cells for targeted treatments. <i>World J Clin Oncol</i> 2025; 16(7): 107007</p> |
URL |
https://www.wjgnet.com/2218-4333/full/v16/i7/107007.htm |
DOI |
https://dx.doi.org/10.5306/wjco.v16.i7.107007 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345